Depression is a debilitating disease that affects over seventeen million Americans of all ages each year. This disease can be painful, both emotionally and physically. The person with depression is not the only one suffering, as those around them will be saddened to see a change from the one they know and love. Fortunately, there are a number of new antidepressants being developed that promise to be even more effective than the current generation.
New antidepressants for fighting depression may be talked or heard about years before they are even released. Each drug must be tested and deemed safe by the Food and Drug Administration before it can be released onto the market. This process is often a long one that takes a great deal of time, since it is important that the administration can certify that the new medicine is one hundred percent safe.
Some examples of newer depression medications include Pristiq, released in 2008, and Tramadol, a pain medicine that was recently discovered to treat depression as well.
Pristiq is an extended release tablet that belongs to the medication group known as serotonin-norepinephrine reuptake inhibitors, or SNRIs. This drug, along with others in its class works by affecting two transmitters in the brain that balance the release of the natural body chemicals norepinephrine and serotonin.
Tramadol is available in a regular pill and also in an extended release version. This drug is a narcotic, so it should not be used by people who have a history of addiction since it may be habit forming. Side effects may include dizziness, drowsiness, sleep problems, or seizures.
It is important that one discusses their options with their doctor to find out which new antidepressants for fighting depression are best for them. One should also understand the risks of their prescribed drug and follow the enclosed directions.
